They notably secrete very special enzymes known as "lytic polysaccharide monooxygenases," or LPMOs, capable of breaking down ...

The importance of individualized treatment of patients with primary and secondary axillary-subclavian vein thrombosis is described with special emphasis on the use of thrombolytic therapy.

The fungi achieve this by secreting an arsenal of enzymes. They notably secrete very special enzymes known as “lytic polysaccharide monooxygenases”, or LPMOs, capable of breaking down the surface of ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...

Recognizing the specificity of phage therapy and its ability to spare beneficial bacteria from adverse effects, we focused our research on phage-derived lytic enzymes." The team initiated their ...